36 matches for your search in the start-up spotlight

rss
matching the following criteria

image description
New Method for Detecting Nanoplastics in Body Fluids

TU Graz and start-up BRAVE Analytics have developed a method for detecting nanoplastics in liquids and determining their composition

16-Apr-2025

Microplastics and the much smaller nanoplastics enter the human body in various ways, for example through food or the air we breathe. A large proportion is excreted, but a certain amount remains in organs, blood and other body fluids. In the FFG bridge project Nano-VISION, which was launched two ...

more

image description
QUANTRO Therapeutics achieves breakthrough in transcriptomic drug discovery

First successful simultaneous 10-target multiplex-screening

09-Jan-2025

QUANTRO Therapeutics, a pioneer in the discovery of first-in-class transcription factor targeting cancer treatments, announced that the company has successfully completed its first ten-target multiplex-screening campaign, which yielded validated hits and functional proof of on-target activity for ...

more

image description
QUANTRO Therapeutics and IMP enter into research collaboration to accelerate transcriptomic drug discovery

28-Oct-2024

QUANTRO Therapeutics (QUANTRO), a pioneer in the discovery of first-in-class transcription factor targeting cancer treatments, announced that the company is entering into a strategic research collaboration with the group of Dr. Johannes Zuber, a world-leading expert in functional genetics and one ...

more

image description
Major investment boosts next-generation 3D printing technology

UpNano receives capital boost for further advancing high-end 2PP 3D printers, materials, and services

21-Oct-2024

UpNano GmbH (Vienna, Austria) announced the completion of its EUR 7M Series A round co-led by aws Gründungsfonds, Novacapital and IGO Innovation GmbH. The funds raised will allow UpNano to accelerate the development of its next generation 2-photon polymerization (2PP) 3D printing technology at a ...

more

image description
invIOs raises €8.2 million in a Series A to finance pipeline progress in immuno-oncology

16-Oct-2024

invIOs GmbH, a privately held biotechnology company developing novel therapies for cancer, announced that the company has raised €8.2 million in a Series A fundraising that includes strong participation from existing shareholders and Ligand Pharmaceuticals. Ligand recently acquired APEIRON, the ...

more

image description
World's largest 3D food printing facility opens in Vienna

‘3D Structuring’ technology brings new plant-based product innovations with unique textures to the supermarket

08-Oct-2024

Vienna, Austria - Austrian food tech start-up Revo Foods has opened the world's largest industrial facility for additive food production in Vienna. The "TASTE FACTORY" uses Revo Foods' proprietary "3D Structuring" technology and enables the introduction of 3D-structured foods with innovative ...

more

image description
QUANTRO Therapeutics receives important Austrian research funding to further develop its platform for the discovery of novel cancer therapies

Austrian Research Promotion Agency FFG awards funding to QUANTRO to accelerate the next development phase of the company's proprietary research platform

08-Aug-2024

QUANTRO Therapeutics GmbH, a pioneer in the development of novel transcription factor-targeted cancer therapies, announced that the company has received an 18-month research grant from the Austrian Research Promotion Agency (FFG). This will support a EUR 1.7 million research project to scale up ...

more

image description
Insect crowdinvesting enters the second round

26-Jul-2024

Invest in the future of the circular economy! Now even more efficient with decentralized fattening systems for organic waste recycling Back in 2022, Reploid (then still known as "Insektianer") raised over half a million euros through crowdinvesting. Since then, the "deepgreen" biotechnology ...

more

image description
APEIRON Biologics to be Acquired by Ligand Pharmaceuticals for USD 100 Million

Ligand also commits to invest up to USD 4 million in APEIRON spin-off, invIOs

10-Jul-2024

APEIRON Biologics AG announced that its shareholders have entered into a definitive agreement to sell their APEIRON shares to US-based Ligand Pharmaceuticals Incorporated for USD 100 million. APEIRON shareholders are also entitled to additional consideration based on future commercial and ...

more

image description
Waterdrop® Rainbow Edition: Celebrating colorful diversity

Limited edition supports LGBTQIA+ organizations

21-Jun-2024

For this year's Pride month, the Austrian microdrink manufacturer is launching an exclusive product range and continues to support LGBTQIA+ organizations Under the motto "Drink with Pride", waterdrop® is once again encouraging its community to celebrate love in all its forms and to show this off ...

more

Page 1 From 4
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE